| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.617 | 0.017 | 0.639 | Antibacterial | 0.636 0.015 DB14569 0.619 0.017 DBMET03123 0.518 0.036 DBMET03125 0.639 0.014 DBMET03126 0.49 0.043 DBMET03124 | DBMET03126 | |
| 0.388 | 0.027 | 0.437 | Hypolipemic | 0.437 0.019 DB14569 0.392 0.027 DBMET03123 0.434 0.019 DBMET03126 0.409 0.024 DBMET03127 | DB14569 | |
| 0.322 | 0.005 | 0.518 | Glutamate receptor agonist | 0.514 0.004 DB14569 0.458 0.004 DBMET03123 0.518 0.004 DBMET03125 0.485 0.004 DBMET03126 0.2 0.01 DBMET03127 0.463 0.004 DBMET03124 | DBMET03125 | |
| 0.243 | 0.017 | 0.391 | Glutamate receptor antagonist | 0.28 0.012 DB14569 0.299 0.01 DBMET03123 0.368 0.006 DBMET03125 0.303 0.01 DBMET03126 0.334 0.008 DBMET03127 0.391 0.005 DBMET03124 | DBMET03124 | |
| 0.204 | 0.009 | 0.292 | Glutamate (mGluR) agonist | 0.24 0.007 DB14569 0.22 0.008 DBMET03123 0.292 0.005 DBMET03125 0.212 0.008 DBMET03126 0.069 0.037 DBMET03127 0.272 0.005 DBMET03124 | DBMET03125 | |
| 0.185 | 0.033 | 0.185 | DNA polymerase I inhibitor | |||
| 0.16 | 0.016 | 0.382 | Glutamate (mGluR) antagonist | 0.257 0.006 DB14569 0.302 0.005 DBMET03123 0.327 0.005 DBMET03125 0.267 0.006 DBMET03126 0.262 0.006 DBMET03127 0.382 0.004 DBMET03124 | DBMET03124 | |
| 0.144 | 0.013 | 0.144 | Purinergic P2X2 antagonist | |||
| 0.215 | 0.101 | 0.215 | DNA synthesis inhibitor | |||
| 0.19 | 0.087 | 0.19 | Pyruvate kinase inhibitor | |||
| 0.117 | 0.031 | 0.117 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.147 | 0.078 | 0.147 | Insulin secretagoues | 0.125 0.103 DB14569 0.135 0.09 DBMET03125 | ||
| 0.262 | 0.2 | 0.464 | Cyclophilin D inhibitor | 0.464 0.062 DB14569 0.283 0.178 DBMET03123 0.28 0.181 DBMET03125 0.461 0.063 DBMET03126 0.422 0.079 DBMET03127 | DB14569 | |
| 0.075 | 0.014 | 0.152 | Glutamate (mGluR group I) agonist | 0.115 0.006 DB14569 0.152 0.005 DBMET03123 0.08 0.012 DBMET03126 | DBMET03123 | |
| 0.178 | 0.119 | 0.188 | Platelet antagonist | 0.188 0.111 DBMET03126 | DBMET03126 | |
| 0.076 | 0.021 | 0.079 | Protein 50S ribosomal subunit inhibitor | 0.079 0.02 DB14569 0.067 0.026 DBMET03123 0.078 0.02 DBMET03125 0.071 0.024 DBMET03126 0.066 0.026 DBMET03124 | DB14569 | |
| 0.087 | 0.033 | 0.243 | Glutamate (mGluR group I) antagonist | 0.17 0.01 DB14569 0.228 0.006 DBMET03123 0.138 0.016 DBMET03125 0.176 0.01 DBMET03126 0.243 0.005 DBMET03127 0.187 0.009 DBMET03124 | DBMET03127 | |
| 0.061 | 0.007 | 0.061 | Purinergic P2X agonist | |||
| 0.056 | 0.009 | 0.056 | Purinergic P2Y2 antagonist | |||
| 0.077 | 0.029 | 0.111 | DNA gyrase inhibitor | 0.097 0.019 DB14569 0.08 0.027 DBMET03123 0.089 0.022 DBMET03125 0.111 0.015 DBMET03126 0.08 0.027 DBMET03127 0.075 0.031 DBMET03124 | DBMET03126 | |
| 0.057 | 0.013 | 0.057 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.048 | 0.015 | 0.108 | DNA gyrase subunit B inhibitor | 0.064 0.008 DB14569 0.056 0.01 DBMET03123 0.053 0.011 DBMET03125 0.1 0.005 DBMET03126 0.108 0.005 DBMET03127 0.047 0.015 DBMET03124 | DBMET03127 | |
| 0.06 | 0.029 | 0.06 | Autotaxin inhibitor | |||
| 0.055 | 0.025 | 0.155 | Glutamate (mGluR5) antagonist | 0.108 0.009 DB14569 0.155 0.005 DBMET03123 0.091 0.012 DBMET03125 0.103 0.01 DBMET03126 0.137 0.006 DBMET03127 0.136 0.006 DBMET03124 | DBMET03123 | |
| 0.127 | 0.1 | 0.482 | Hemostatic | 0.205 0.031 DB14569 0.224 0.026 DBMET03123 0.465 0.005 DBMET03125 0.237 0.024 DBMET03126 0.131 0.094 DBMET03127 0.482 0.005 DBMET03124 | DBMET03124 | |
| 0.031 | 0.005 | 0.031 | Purinergic P2Y1 antagonist | |||
| 0.107 | 0.082 | 0.107 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.066 | 0.042 | 0.066 | Purinergic P2 antagonist | |||
| 0.028 | 0.005 | 0.028 | Purinergic receptor agonist | |||
| 0.028 | 0.005 | 0.028 | Purinergic P2 agonist | |||
| 0.042 | 0.019 | 0.223 | Glutamate (mGluR group II) agonist | 0.1 0.007 DB14569 0.054 0.014 DBMET03123 0.223 0.004 DBMET03125 0.082 0.009 DBMET03126 0.177 0.004 DBMET03124 | DBMET03125 | |
| 0.193 | 0.173 | 0.193 | Immunomodulator | |||
| 0.022 | 0.005 | 0.022 | Purinergic P2Y agonist | |||
| 0.029 | 0.013 | 0.029 | Toll-Like receptor 4 agonist | |||
| 0.169 | 0.155 | 0.169 | RNA-directed DNA polymerase inhibitor | |||
| 0.034 | 0.021 | 0.219 | Glutamate (mGluR2) agonist | 0.091 0.007 DB14569 0.047 0.015 DBMET03123 0.219 0.004 DBMET03125 0.072 0.009 DBMET03126 0.172 0.004 DBMET03124 | DBMET03125 | |
| 0.031 | 0.018 | 0.044 | DNA topoisomerase IV inhibitor | 0.04 0.009 DB14569 0.039 0.009 DBMET03123 0.042 0.008 DBMET03125 0.044 0.007 DBMET03126 0.041 0.008 DBMET03124 | DBMET03126 | |
| 0.02 | 0.014 | 0.02 | Inosine monophosphate dehydrogenase 1 inhibitor | |||
| 0.01 | 0.004 | 0.01 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.083 | 0.077 | 0.538 | MAO A inhibitor | 0.538 0.005 DB14569 0.522 0.005 DBMET03123 0.254 0.02 DBMET03126 | DB14569 | |
| 0.098 | 0.093 | 0.545 | MAO inhibitor | 0.545 0.006 DB14569 0.442 0.009 DBMET03123 0.244 0.029 DBMET03126 0.152 0.059 DBMET03127 | DB14569 | |
| 0.041 | 0.036 | 0.198 | Stearoyl-CoA desaturase inhibitor | 0.198 0.004 DB14569 0.095 0.008 DBMET03123 0.144 0.004 DBMET03125 0.103 0.007 DBMET03126 0.15 0.004 DBMET03127 0.062 0.017 DBMET03124 | DB14569 | |
| 0.05 | 0.047 | 0.05 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.206 | 0.229 | 0.421 | Analgesic | 0.329 0.121 DB14569 0.273 0.164 DBMET03123 0.421 0.076 DBMET03126 0.32 0.127 DBMET03127 | DBMET03126 | |
| 0.025 | 0.05 | 0.05 | AMPA receptor agonist | 0.041 0.017 DB14569 0.041 0.016 DBMET03123 0.042 0.015 DBMET03126 0.05 0.009 DBMET03127 | DBMET03127 | |
| 0.014 | 0.042 | 0.061 | Somatostatin 5 antagonist | 0.045 0.015 DB14569 0.038 0.019 DBMET03123 0.061 0.01 DBMET03125 0.051 0.013 DBMET03126 0.054 0.012 DBMET03124 | DBMET03125 | |
| 0.023 | 0.051 | 0.188 | Nicotinic acid receptor 2 agonist | 0.049 0.014 DB14569 0.041 0.02 DBMET03123 0.188 0.004 DBMET03125 0.086 0.007 DBMET03126 0.095 0.006 DBMET03127 0.177 0.004 DBMET03124 | DBMET03125 | |
| 0.007 | 0.039 | 0.016 | 5 Lipoxygenase activating protein inhibitor | 0.013 0.01 DB14569 0.016 0.006 DBMET03127 | DBMET03127 | |
| 0.066 | 0.11 | 0.224 | Alcohol dehydrogenase inhibitor | 0.224 0.01 DBMET03125 0.089 0.066 DBMET03127 0.146 0.021 DBMET03124 | DBMET03125 | |
| 0.01 | 0.066 | 0.031 | Squalene synthetase inhibitor | 0.031 0.023 DBMET03126 | DBMET03126 | |
| 0.011 | 0.067 | 0.059 | Bradykinin B1 receptor antagonist | 0.026 0.021 DB14569 0.035 0.014 DBMET03123 0.059 0.008 DBMET03127 | DBMET03127 | |
| 0.028 | 0.107 | 0.049 | DNA gyrase subunit A inhibitor | 0.046 0.022 DB14569 0.049 0.019 DBMET03125 0.047 0.02 DBMET03126 0.041 0.033 DBMET03124 | DBMET03125 | |
| 0.063 | 0.147 | 0.122 | EphA2 antagonist | 0.122 0.053 DB14569 0.121 0.054 DBMET03125 | DB14569 | |
| 0.022 | 0.107 | 0.089 | Nicotinic acid receptor 1 agonist | 0.038 0.031 DB14569 0.054 0.018 DBMET03123 0.063 0.015 DBMET03125 0.056 0.017 DBMET03126 0.048 0.021 DBMET03127 0.089 0.009 DBMET03124 | DBMET03124 | |
| 0.017 | 0.108 | 0.091 | Glutamate (mGluR group II) antagonist | 0.052 0.015 DB14569 0.091 0.005 DBMET03125 0.053 0.014 DBMET03126 0.042 0.022 DBMET03124 | DBMET03125 | |
| 0.005 | 0.097 | 0.019 | Free fatty acid receptor 1 agonist | 0.019 0.011 DBMET03127 | DBMET03127 | |
| 0.017 | 0.121 | 0.1 | Oleamide hydrolase inhibitor | 0.079 0.013 DB14569 0.079 0.013 DBMET03123 0.079 0.013 DBMET03126 0.1 0.009 DBMET03127 | DBMET03127 | |
| 0.012 | 0.134 | 0.036 | Cholesterol ester transfer protein antagonist | 0.031 0.022 DB14569 0.033 0.019 DBMET03123 0.036 0.017 DBMET03126 | DBMET03126 | |
| 0.096 | 0.225 | 0.167 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.143 0.085 DB14569 0.14 0.092 DBMET03123 0.144 0.084 DBMET03125 0.167 0.046 DBMET03126 0.141 0.091 DBMET03124 | DBMET03126 | |
| 0.035 | 0.164 | 0.066 | Protein kinase B beta inhibitor | 0.066 0.064 DBMET03124 | DBMET03124 | |
| 0.037 | 0.171 | 0.165 | Potassium channel (Ca-activated) activator | 0.165 0.023 DBMET03125 0.085 0.07 DBMET03124 | DBMET03125 | |
| 0.007 | 0.148 | 0.079 | Leukotriene D4 antagonist | 0.07 0.008 DBMET03125 0.079 0.007 DBMET03126 0.059 0.009 DBMET03124 | DBMET03126 | |
| 0.008 | 0.165 | 0.029 | AMPA 2 receptor antagonist | 0.028 0.022 DBMET03125 0.029 0.021 DBMET03127 | DBMET03127 | |
| 0.006 | 0.181 | 0.044 | Bradykinin antagonist | 0.044 0.018 DBMET03127 | DBMET03127 | |
| 0.06 | 0.251 | 0.161 | Anticoagulant | 0.129 0.102 DB14569 0.161 0.071 DBMET03125 0.16 0.072 DBMET03126 0.149 0.082 DBMET03124 | DBMET03125 | |
| 0.018 | 0.217 | 0.045 | Neuropeptide Y5 antagonist | 0.045 0.042 DBMET03123 | DBMET03123 | |
| 0.121 | 0.323 | 0.352 | Antiobesity | 0.352 0.086 DB14569 0.296 0.119 DBMET03123 0.333 0.096 DBMET03126 0.308 0.111 DBMET03127 | DB14569 | |
| 0.01 | 0.217 | 0.101 | Phosphodiesterase 3B inhibitor | 0.101 0.011 DBMET03125 0.081 0.015 DBMET03124 | DBMET03125 | |
| 0.038 | 0.276 | 0.117 | GABA receptor agonist | 0.095 0.083 DBMET03123 0.117 0.059 DBMET03127 | DBMET03127 | |
| 0.004 | 0.252 | 0.061 | Glutamate (mGluR2) antagonist | 0.035 0.015 DB14569 0.061 0.006 DBMET03125 0.033 0.016 DBMET03126 0.029 0.022 DBMET03124 | DBMET03125 | |
| 0.01 | 0.257 | 0.042 | Glutamate (mGluR3) antagonist | 0.039 0.022 DBMET03126 0.042 0.018 DBMET03127 | DBMET03127 | |
| 0.005 | 0.256 | 0.047 | Vascular adhesion protein 1 inhibitor | 0.047 0.018 DB14569 0.037 0.029 DBMET03123 | DB14569 | |
| 0.029 | 0.287 | 0.101 | Hepatocyte growth factor antagonist | 0.101 0.05 DBMET03127 | DBMET03127 | |
| 0.028 | 0.317 | 0.069 | Phosphodiesterase VIII inhibitor | 0.068 0.059 DBMET03125 0.069 0.057 DBMET03124 | DBMET03124 | |
| 0.009 | 0.305 | 0.166 | MAO B inhibitor | 0.166 0.033 DB14569 0.118 0.052 DBMET03123 | DB14569 | |
| 0.005 | 0.302 | 0.047 | AMPA receptor antagonist | 0.047 0.034 DBMET03127 | DBMET03127 | |
| 0.02 | 0.32 | 0.071 | Transcription factor AP-1 inhibitor | 0.071 0.029 DBMET03127 | DBMET03127 | |
| 0.021 | 0.324 | 0.223 | Phosphodiesterase 3A inhibitor | 0.223 0.006 DBMET03125 0.222 0.006 DBMET03124 | DBMET03125 | |
| 0.01 | 0.321 | 0.054 | TRPA1 antagonist | 0.054 0.053 DBMET03127 | DBMET03127 | |
| 0.032 | 0.359 | 0.062 | MAP kinase kinase 8 inhibitor | 0.062 0.06 DBMET03127 | DBMET03127 | |
| 0.128 | 0.46 | 0.373 | Antiinflammatory | 0.262 0.254 DB14569 0.373 0.157 DBMET03126 0.338 0.182 DBMET03127 | DBMET03126 | |
| 0.007 | 0.35 | 0.079 | Calcium release-activated channel blocker | 0.079 0.004 DBMET03127 | DBMET03127 | |
| 0.007 | 0.352 | 0.044 | Nicotinic acid receptor agonist | 0.044 0.018 DBMET03125 0.032 0.03 DBMET03127 0.042 0.019 DBMET03124 | DBMET03125 | |
| 0.041 | 0.391 | 0.253 | Anticonvulsant | 0.253 0.056 DBMET03125 | DBMET03125 | |
| 0.034 | 0.39 | 0.323 | Phosphodiesterase 7B inhibitor | 0.312 0.004 DBMET03125 0.323 0.004 DBMET03124 | DBMET03124 | |
| 0.039 | 0.404 | 0.149 | Interleukin 1 antagonist | 0.149 0.058 DBMET03127 | DBMET03127 | |
| 0.013 | 0.395 | 0.044 | Glutamate (mGluR group III) agonist | 0.044 0.029 DBMET03127 | DBMET03127 | |
| 0.023 | 0.434 | 0.09 | Uric acid excretion stimulant | 0.09 0.065 DBMET03126 | DBMET03126 | |
| 0.017 | 0.445 | 0.078 | GABA A receptor agonist | 0.078 0.068 DBMET03127 | DBMET03127 | |
| 0.069 | 0.511 | 0.203 | Catenin beta inhibitor | 0.18 0.052 DBMET03125 0.203 0.029 DBMET03124 | DBMET03124 | |
| 0.006 | 0.475 | 0.041 | Factor XIa inhibitor | 0.041 0.028 DBMET03124 | DBMET03124 | |
| 0.008 | 0.483 | 0.075 | Diacylglycerol O-acyltransferase inhibitor | 0.075 0.017 DBMET03125 0.073 0.018 DBMET03127 0.051 0.034 DBMET03124 | DBMET03125 | |
| 0.003 | 0.5 | 0.055 | Angiotensin AT1A receptor antagonist | 0.052 0.004 DBMET03125 0.055 0.004 DBMET03124 | DBMET03124 | |
| 0.009 | 0.51 | 0.091 | Phosphodiesterase III inhibitor | 0.091 0.027 DBMET03125 0.081 0.035 DBMET03124 | DBMET03125 | |
| 0.003 | 0.533 | 0.033 | AMPA 3 receptor antagonist | 0.033 0.018 DBMET03127 | DBMET03127 | |
| 0.024 | 0.605 | 0.151 | Interleukin 1b antagonist | 0.151 0.039 DBMET03127 | DBMET03127 | |
| 0.003 | 0.589 | 0.083 | Angiotensin AT2 receptor antagonist | 0.083 0.005 DBMET03125 0.083 0.005 DBMET03124 | DBMET03124 | |
| 0.003 | 0.592 | 0.053 | MAP3K8 inhibitor | 0.053 0.004 DBMET03127 | DBMET03127 | |
| 0.005 | 0.639 | 0.255 | MAP kinase kinase kinase inhibitor | 0.115 0.054 DBMET03125 0.255 0.009 DBMET03127 0.1 0.067 DBMET03124 | DBMET03127 | |
| 0.032 | 0.667 | 0.218 | Toll-Like receptor agonist | 0.218 0.181 DBMET03127 | DBMET03127 | |
| 0.026 | 0.706 | 0.222 | Toll-Like receptor 7 agonist | 0.222 0.175 DBMET03127 | DBMET03127 | |
| 0.002 | 0.683 | 0.047 | Kainate receptor antagonist | 0.047 0.023 DBMET03127 | DBMET03127 | |
| 0.003 | 0.775 | 0.057 | Leukotriene C antagonist | 0.057 0.038 DBMET03125 | DBMET03125 | |
| 0.005 | 0.777 | 0.106 | MAP kinase kinase inhibitor | 0.106 0.088 DBMET03127 | DBMET03127 | |
| 0.003 | 0.807 | 0.032 | Protocollagen prolyl hydroxylase inhibitor | 0.032 0.013 DBMET03127 | DBMET03127 | |
| 0.005 | 0.81 | 0.063 | Fatty acid synthase inhibitor | 0.063 0.032 DBMET03125 | DBMET03125 | |
| 0.011 | 0.841 | 0.07 | Bombesin 3 receptor antagonist | 0.064 0.029 DBMET03125 0.07 0.024 DBMET03124 | DBMET03124 | |
| 0.004 | 0.853 | 0.065 | Phosphodiesterase VII inhibitor | 0.065 0.04 DBMET03124 | DBMET03124 | |
| 0.016 | 0.973 | 0.255 | Sodium/bile acid cotransporter inhibitor | 0.255 0.123 DBMET03127 | DBMET03127 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |